Jay Olson
Stock Analyst at Oppenheimer
(4.19)
# 470
Out of 5,124 analysts
245
Total ratings
45.45%
Success rate
17.12%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Outperform | $250 → $750 | $294.74 | +154.46% | 3 | Dec 15, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Outperform | $28 → $58 | $40.40 | +43.56% | 4 | Dec 9, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Outperform | $600 → $650 | $582.34 | +11.62% | 12 | Nov 20, 2025 | |
| IBIO iBio, Inc. | Initiates: Outperform | $5 | $1.93 | +159.07% | 1 | Oct 21, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $84 → $90 | $79.11 | +13.77% | 4 | Oct 8, 2025 | |
| IMRX Immuneering | Maintains: Outperform | $21 → $30 | $6.58 | +355.93% | 3 | Sep 25, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Outperform | $48 → $44 | $7.05 | +524.11% | 4 | Aug 11, 2025 | |
| MNMD Mind Medicine (MindMed) | Reinstates: Outperform | $25 | $13.39 | +86.71% | 1 | Aug 4, 2025 | |
| ATAI Atai Beckley | Initiates: Outperform | $14 | $4.09 | +242.30% | 1 | Jul 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Perform | $19 → $22 | $26.71 | -17.63% | 15 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $9.55 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $4.30 | +1,411.63% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $65 | $1.83 | +3,451.91% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $1.74 | +647.13% | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $79.65 | -5.84% | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $90 | $42.28 | +112.87% | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $42 | $16.51 | +154.39% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $41 → $33 | $43.83 | -24.71% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $40 | $8.99 | +344.94% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $20 | $3.32 | +502.41% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $5.92 | +406.76% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $270 → $255 | $175.99 | +44.89% | 25 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $82 | $98.77 | -16.98% | 14 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $10 | $23.01 | -56.54% | 4 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $138 | $35.18 | +292.27% | 8 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $8 | $3.22 | +148.45% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $380 | $327.31 | +16.10% | 23 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $216 → $219 | $141.83 | +54.41% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $12 | $2.05 | +485.37% | 6 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 | $3.93 | +358.02% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 | $11.57 | +764.30% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $95 | $52.44 | +81.16% | 6 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $0.75 | +3,234.67% | 1 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 | $1.35 | +566.67% | 4 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,200 → $500 | $1.16 | +43,003.45% | 4 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $25 → $21 | $15.77 | +33.16% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $4.83 | - | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $84 | $18.46 | +355.04% | 1 | Mar 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $1.63 | - | 3 | Jul 11, 2017 |
Praxis Precision Medicines
Dec 15, 2025
Maintains: Outperform
Price Target: $250 → $750
Current: $294.74
Upside: +154.46%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Outperform
Price Target: $28 → $58
Current: $40.40
Upside: +43.56%
Madrigal Pharmaceuticals
Nov 20, 2025
Maintains: Outperform
Price Target: $600 → $650
Current: $582.34
Upside: +11.62%
iBio, Inc.
Oct 21, 2025
Initiates: Outperform
Price Target: $5
Current: $1.93
Upside: +159.07%
Ionis Pharmaceuticals
Oct 8, 2025
Maintains: Outperform
Price Target: $84 → $90
Current: $79.11
Upside: +13.77%
Immuneering
Sep 25, 2025
Maintains: Outperform
Price Target: $21 → $30
Current: $6.58
Upside: +355.93%
Bicycle Therapeutics
Aug 11, 2025
Maintains: Outperform
Price Target: $48 → $44
Current: $7.05
Upside: +524.11%
Mind Medicine (MindMed)
Aug 4, 2025
Reinstates: Outperform
Price Target: $25
Current: $13.39
Upside: +86.71%
Atai Beckley
Jul 29, 2025
Initiates: Outperform
Price Target: $14
Current: $4.09
Upside: +242.30%
ACADIA Pharmaceuticals
Jun 26, 2025
Maintains: Perform
Price Target: $19 → $22
Current: $26.71
Upside: -17.63%
May 27, 2025
Downgrades: Perform
Price Target: n/a
Current: $9.55
Upside: -
May 21, 2025
Initiates: Outperform
Price Target: $65
Current: $4.30
Upside: +1,411.63%
May 15, 2025
Maintains: Outperform
Price Target: $80 → $65
Current: $1.83
Upside: +3,451.91%
May 14, 2025
Maintains: Outperform
Price Target: $15 → $13
Current: $1.74
Upside: +647.13%
May 8, 2025
Maintains: Outperform
Price Target: $70 → $75
Current: $79.65
Upside: -5.84%
Mar 14, 2025
Upgrades: Outperform
Price Target: $90
Current: $42.28
Upside: +112.87%
Mar 3, 2025
Maintains: Outperform
Price Target: $50 → $42
Current: $16.51
Upside: +154.39%
Jan 24, 2025
Downgrades: Perform
Price Target: $41 → $33
Current: $43.83
Upside: -24.71%
Jan 13, 2025
Maintains: Outperform
Price Target: $60 → $40
Current: $8.99
Upside: +344.94%
Dec 11, 2024
Maintains: Outperform
Price Target: $80 → $20
Current: $3.32
Upside: +502.41%
Dec 6, 2024
Initiates: Outperform
Price Target: $30
Current: $5.92
Upside: +406.76%
Oct 31, 2024
Maintains: Outperform
Price Target: $270 → $255
Current: $175.99
Upside: +44.89%
Oct 30, 2024
Maintains: Outperform
Price Target: $81 → $82
Current: $98.77
Upside: -16.98%
Oct 17, 2024
Maintains: Outperform
Price Target: $9 → $10
Current: $23.01
Upside: -56.54%
Sep 25, 2024
Reiterates: Outperform
Price Target: $138
Current: $35.18
Upside: +292.27%
Aug 14, 2024
Assumes: Outperform
Price Target: $8
Current: $3.22
Upside: +148.45%
Aug 7, 2024
Maintains: Outperform
Price Target: $380
Current: $327.31
Upside: +16.10%
Aug 2, 2024
Maintains: Outperform
Price Target: $216 → $219
Current: $141.83
Upside: +54.41%
Jun 18, 2024
Maintains: Perform
Price Target: $12
Current: $2.05
Upside: +485.37%
May 15, 2024
Maintains: Outperform
Price Target: $18
Current: $3.93
Upside: +358.02%
May 15, 2024
Maintains: Outperform
Price Target: $100
Current: $11.57
Upside: +764.30%
May 10, 2024
Maintains: Outperform
Price Target: $102 → $95
Current: $52.44
Upside: +81.16%
Apr 12, 2024
Initiates: Outperform
Price Target: $25
Current: $0.75
Upside: +3,234.67%
Mar 27, 2024
Maintains: Outperform
Price Target: $9
Current: $1.35
Upside: +566.67%
Nov 30, 2023
Maintains: Outperform
Price Target: $1,200 → $500
Current: $1.16
Upside: +43,003.45%
Nov 22, 2023
Maintains: Perform
Price Target: $25 → $21
Current: $15.77
Upside: +33.16%
Oct 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $4.83
Upside: -
Mar 20, 2018
Maintains: Outperform
Price Target: $70 → $84
Current: $18.46
Upside: +355.04%
Jul 11, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1.63
Upside: -